Bcl-2_NN
protein_NN
inhibits_VBZ
bufalin-induced_JJ
apoptosis_NN
through_IN
inhibition_NN
of_IN
mitogen-activated_JJ
protein_NN
kinase_NN
activation_NN
in_IN
human_JJ
leukemia_NN
U937_NN
cells_NNS
._.

In_IN
a_DT
previous_JJ
study_NN
,_,
we_PRP
demonstrated_VBD
that_IN
bufalin_NN
,_,
which_WDT
is_VBZ
an_DT
active_JJ
principle_NN
of_IN
Chinese_JJ
medicine_NN
,_,
chan_NN
`_NN
su_NN
,_,
caused_VBD
apoptosis_NN
in_IN
human_JJ
leukemia_NN
U937_NN
cells_NNS
by_IN
anomalous_JJ
activation_NN
of_IN
mitogen-activated_JJ
protein_NN
kinase_NN
-LRB-_-LRB-
MAPK_NN
-RRB-_-RRB-
via_IN
the_DT
signaling_VBG
pathway_NN
of_IN
Ras_NN
,_,
Raf-1_NN
,_,
and_CC
MAPK_NN
kinase-1_NN
._.

Here_RB
,_,
we_PRP
report_VBP
the_DT
effect_NN
of_IN
overexpression_NN
of_IN
bcl-2_NN
in_IN
U937_NN
cells_NNS
on_IN
the_DT
signaling_VBG
pathway_NN
of_IN
apoptosis_NN
that_WDT
is_VBZ
induced_VBN
by_IN
bufalin_NN
._.

The_DT
results_NNS
indicated_VBD
that_IN
the_DT
apoptosis_NN
induced_VBN
by_IN
bufalin_NN
in_IN
U937_NN
cells_NNS
was_VBD
significantly_RB
inhibited_VBN
by_IN
overexpression_NN
of_IN
the_DT
Bcl-2_NN
protein_NN
._.

No_DT
significant_JJ
difference_NN
was_VBD
detected_VBN
in_IN
the_DT
activation_NN
of_IN
MAPK_NN
kinase-1_NN
that_WDT
is_VBZ
induced_VBN
by_IN
bufalin_NN
in_IN
wild-type_JJ
or_CC
Bcl-2-overexpressed_JJ
U937_NN
cells_NNS
;_:
however_RB
,_,
the_DT
activation_NN
of_IN
MAPK_NN
by_IN
bufalin_NN
was_VBD
significantly_RB
attenuated_VBN
in_IN
the_DT
cells_NNS
overexpressing_VBG
Bcl-2_NN
._.

Bufalin_NN
treatment_NN
activated_JJ
activator_NN
protein-1_NN
transcriptional_JJ
activity_NN
;_:
however_RB
,_,
this_DT
activation_NN
was_VBD
decreased_VBN
to_TO
40_CD
%_NN
in_IN
bcl-2-overexpressed_JJ
U937_NN
cells_NNS
._.

These_DT
results_NNS
indicate_VBP
that_IN
Bcl-2_NN
acts_VBZ
downstream_JJ
of_IN
MAPK_NN
kinase-1_NN
but_CC
upstream_JJ
of_IN
MAPK_NN
and_CC
suggest_VBP
that_IN
,_,
in_IN
the_DT
signaling_VBG
pathway_NN
of_IN
the_DT
apoptotic_JJ
process_NN
induced_VBN
by_IN
bufalin_NN
,_,
the_DT
transcriptional_JJ
activity_NN
of_IN
activator_NN
protein-1_NN
may_MD
be_VB
down-regulated_VBN
through_IN
the_DT
inhibition_NN
of_IN
MAPK_NN
activity_NN
by_IN
Bcl-2_NN
._.

